Created in 2000 (Switzerland), BRONCONEX own 402 sister brands and 17477 competing brands. BRONCONEX is owned by Merck & Co, listed on the stock exchange of New York The sector of BRONCONEX is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Merck & Co
(BRONCONEX)
over 5 years*
USD 219.35